Used as an intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure allows for easy modification and conjugation, making it valuable in creating compounds with enhanced bioavailability and receptor selectivity. Commonly employed in the production of psychotropic drugs, including antipsychotics and antidepressants, due to the piperazine moiety’s affinity for neurotransmitter receptors. Also utilized in research settings for designing novel drug candidates and optimizing lead compounds in medicinal chemistry.